| Basics |
| Company: |
Kyverna Therapeutics, Inc. Common Stock |
| IPO Date: |
February 9, 2024 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$120.02M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.43 | 4.20%
|
| Avg Daily Range (30 D): |
$0.12 | 3.67%
|
| Avg Daily Range (90 D): |
$0.19 | 4.27%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.37M |
| Avg Daily Volume (30 D): |
.36M |
| Avg Daily Volume (90 D): |
.31M |
| Trade Size |
| Avg Trade Size (Sh.): |
93 |
| Avg Trade Size (Sh.) (30 D): |
137 |
| Avg Trade Size (Sh.) (90 D): |
103 |
| Institutional Trades |
| Total Inst.Trades: |
108 |
| Avg Inst. Trade: |
$1.86M |
| Avg Inst. Trade (30 D): |
$3.27M |
| Avg Inst. Trade (90 D): |
$3.2M |
| Avg Inst. Trade Volume: |
.14M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.67M |
| Avg Closing Trade (30 D): |
$3.06M |
| Avg Closing Trade (90 D): |
$3.06M |
| Avg Closing Volume: |
213.96K |
|
|
|
|
| News |
Feb 6, 2025 @ 6:51 PM
Investors in Kyverna Therapeutics, Inc. Should Con...
Source: The Gross Law Firm
|
Feb 3, 2025 @ 9:00 PM
KYTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Feb 2, 2025 @ 2:48 PM
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates ...
Source: Faruqi & Faruqi, Llp
|
Jan 30, 2025 @ 6:45 PM
Levi & Korsinsky Announces the Filing of a Securit...
Source: N/A
|
Jan 30, 2025 @ 3:33 AM
KYVERNA THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILE...
Source: Claimsfiler
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
|
$-.8
|
$-.67
|
|
Diluted EPS
|
|
$-.8
|
$-.67
|
|
Revenue
|
$
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ -34.49M
|
$ -28.8M
|
|
Operating Income / Loss
|
$
|
$ -38.77M
|
$ -33.44M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ -26.97M
|
$ -92.67M
|
|
PE Ratio
|
|
|
|
|
